Brookfield Asset Management Inc. Charles River Laboratories International, Inc. Transaction History

Brookfield Asset Management Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$197.11 - $250.07 $2.74 Million - $3.47 Million	-13,895 Reduced 27.74%	36,187 $7.88 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $3.01 Million - $4.13 Million	16,473 Added 49.01%	50,082 $9.86 Million
Q2 2022 Nov 16, 2022	SELL	$204.13 - $302.4 $3.36 Million - $4.98 Million	-16,473 Reduced 32.89%	33,609 $7.19 Million
Q2 2022 Aug 15, 2022	BUY	$204.13 - $302.4 $1.1 Million - $1.63 Million	5,406 Added 19.17%	33,609 $7.19 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $4.11 Million - $5.83 Million	16,096 Added 132.95%	28,203 $8.01 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $1.51 Million - $1.93 Million	4,308 Added 55.24%	12,107 $4.56 Million
Q3 2021 Nov 16, 2021	BUY	$372.64 - $458.3 $463,936 - $570,583	1,245 Added 19.0%	7,799 $3.22 Million
Q2 2021 Aug 17, 2021	SELL	$294.17 - $371.65 $590,693 - $746,273	-2,008 Reduced 23.45%	6,554 $2.42 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $1.5 Million - $1.94 Million	8,562 New	8,562 $1.94 Million

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.